Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil

Bone Marrow Transplant. 2024 Jul;59(7):1040-1042. doi: 10.1038/s41409-024-02283-6. Epub 2024 Apr 13.

¹ Department of Medical Imaging, Hematology and Oncology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil. camila.donadel@hemocentro.fmrp.usp.br.
² Department of Medical Imaging, Hematology and Oncology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.
³ Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil.
⁴ Department of Hematology, Hemotherapy & Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology. Hospital das Clínicas da Faculdade de Medicina, University of São Paulo (USP), São Paulo, Brazil.

No abstract available

Publication types